Swiss National Bank’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
61,873
+20,000
| +48% | +$401K | ﹤0.01% | 2040 |
|
|
2025
Q1 | $824K | Hold |
41,873
| – | – | ﹤0.01% | 2212 |
|
|
2024
Q4 | $942K | Buy |
41,873
+5,100
| +14% | +$115K | ﹤0.01% | 2227 |
|
|
2024
Q3 | $939K | Hold |
36,773
| – | – | ﹤0.01% | 2239 |
|
|
2024
Q2 | $859K | Hold |
36,773
| – | – | ﹤0.01% | 2238 |
|
|
2024
Q1 | $647K | Buy |
36,773
+300
| +0.8% | +$5.28K | ﹤0.01% | 2398 |
|
|
2023
Q4 | $505K | Sell |
36,473
-4,200
| -10% | -$58.1K | ﹤0.01% | 2473 |
|
|
2023
Q3 | $556K | Sell |
40,673
-8,500
| -17% | -$116K | ﹤0.01% | 2483 |
|
|
2023
Q2 | $1M | Buy |
+49,173
| New | +$1M | ﹤0.01% | 2290 |
|